Our attorneys have filed a mass tort lawsuit on behalf of patients who took the blood thinner Xarelto (rivaroxaban) and suffered critical bleeding events. Pharmaceutical firms, such as the makers of Xarelto, have a duty to make sure that their drugs are reasonably secure for use – and failure to complete so might be grounds for compensation. Our lawyers are functioning difficult to have those hurt by the drug the compensation they are entitled to.
While bleeding is a frequent complication related with anticoagulants, it has been alleged that Xarelto is a lot more unsafe than traditional blood thinners simply because no antidote exists to reverse its blood-thinning effects. This signifies that, inside the event of an emergency, patients might be at risk for irreversible bleeding troubles, like life-threatening internal and gastrointestinal hemorrhaging.
In case you or even a loved one particular suffered a severe bleeding occasion right after taking Xarelto, you might have legal recourse. For far more info, contact us these days to possess your case reviewed, totally free of charge.
xarelto-compensation-photoThe plaintiffs in these lawsuits are in search of compensation from Bayer and Janssen for past and future healthcare bills, lost wages, discomfort and suffering and, in cases of death, funeral costs. Furthermore, they’re looking for punitive damages, that are generally awarded to punish the defendant and deter other organizations from acting similarly.
Why Are Lawsuits Becoming Filed?
Bayer and Johnson & Johnson’s Janssen Pharmaceuticals, Inc. are facing several Xarelto lawsuits alleging that the drug is harmful and defective. The plaintiffs claim that, unlike standard anticoagulants (e.g. warfarin, Coumadin) whose blood-thinning effects can be reversed using vitamin K, there is no antidote available for Xarelto. Due to the fact of this, the lawsuits claim, doctors have no effective means of stopping Xarelto users from bleeding inside the occasion of an emergency. Plaintiffs inside the lawsuits allege serious and fatal injuries, such as cerebral hemorrhaging and gastrointestinal bleeds, from use of the drug.
In addition to these risks, lawsuits against Bayer and Johnson & Johnson’s Janssen Pharmaceuticals are alleging:
The manufacturers of Xarelto marketed the drug as a superior in the field of anticoagulants despite studies finding higher rates of gastrointestinal (GI tract) bleeding and transfusions in Xarelto users than users of certain competitors.
The makers of the drug continue to market Xarelto as a protected anticoagulant option.
Doctors and health-related staff were not properly made aware of methods to stabilize and treat a Xarelto user inside the occasion of a bleeding complication.
Users of Xarelto were not adequately warned of the health risks of suffering a fatal bleeding occasion.
Xarelto is linked to significant bleeding complications, excessive blood loss, intracranial hemorrhaging, eye bleeding (vitreous hemorrhage), stomach bleeding, gastrointestinal bleeding, wound infections from inhibited clotting, and lack of effectiveness in preventing harmful clotting.
Visit this page for more data on the alleged health risks of Xarelto.
Multidistrict Litigation Trial Dates Set
The attorneys inside click the following web page Complex Litigation Group have filed lawsuits on behalf of injured clients. The claims will proceed through multidistrict litigation (MDL), which currently entails four trials, scheduled for Fall 2016, in which random groups of plaintiffs will be chosen to represent the group.